comprehensive -WSS

comprehensive

author：leisure time 2025-09-27 23:00:54 - browse：2686

Sammy Kimball for STAT

Can Novavax finally get it right? What’s a “triple-G” drug? And is Novo Nordisk losing ground?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Our colleague Elaine Chen joins us to explain how the era of Wegovy could be short-lived in light of powerful new weight-loss medicines from Eli Lilly. Then, John Jacobs, the new CEO of Novavax, stops by to explain his plan to right the ship at a company that has struggled to make the most of its potent Covid-19 vaccine.

For more on what we cover, here’s the news on Lilly; here’s more on Novavax; here’s where you can find episodes of Color Code; and here’s where you can subscribe to the First Opinion Podcast.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： New air purifier tech could be key to improving indoor air quality
Next article： Mass General totes up its waste in a move to tackle climate change

focus

WSS

Indian pharmaceutical industry in denial over drug

Vir antibody drug aimed at influenza A fails in clinical trial

CZI to create biohub to build anti

7 more heat

Ending racial health disparities hinges on penalties, political will

Wife of Gilgo Beach murder suspect files for divorce, court filing shows

hotspot

comprehensive

hotspot

Wildfire smoke exposes gaps in outdoor worker protections

Readout LOUD podcast: Live from the 2023 STAT Summit

Psychedelics group wrestles with new pharma identity

Winning ticket for $1 billion Powerball jackpot sold in California

Medicare proposal to cover medical devices draws a mixed reaction

Driven by the pandemic, applicants flood public health schools

At least 13 dead in Texas as scorching temps continue

Mass General totes up its waste in a move to tackle climate change

Hepatitis C has a cure — but many Americans still lack access to it

A Q&A with Gavi’s Seth Berkley on vaccines, Covid, and more

knowledge

STAT Summit: Ending the crisis of Black deaths in the U.S.

Merck, Daiichi strike cancer drug pact worth up to $22 billion

Why Congress must ban federal programs from using QALYs

CZI to create biohub to build anti

FDA clears Verve to begin U.S. study of gene

Key lawmaker blasts Congress’ efforts on addiction: ‘Shame on us’

Wikipedia

focus

focus

focus